Qube Research & Technologies (QRT)
PALI icon

Qube Research & Technologies (QRT)’s Palisade Bio PALI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261K Buy
+148,970
New +$271K ﹤0.01% 2899

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PALI Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Palisade Bio (PALI) in Q1 2026: 148,970 shares worth $261K. The stake represents ﹤0.01% of the portfolio and ranks #2899 among its holdings.

96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Qube Research & Technologies (QRT) held 148,970 shares of Palisade Bio worth $261K as of Q1 2026.
  • Palisade Bio was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Palisade Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2899 holding.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.